Genomic microarray for diagnosing genetic abnormalities in children

Coverage decision: Not Covered (Effective date: July 1, 2018)

L&I’s Office of the Medical Director has determined that the HTCC’s determination about genomic microarray for diagnosing genetic abnormalities in children does not apply to Washington’s workers’ compensation, which only covers work-related injuries or occupational disease.

Background Information

The State Health Technology Clinical Committee (HTCC) first reviewed genomic microarray for diagnosing genetic abnormalities in children and made a determination in May 2016, which was finalized on July 8, 2016. The committee’s determination, based on a systematic review of the evidence of safety, efficacy and cost-effectiveness, is that the testing is a covered benefit with conditions for children with congenital anomalies, intellectual disability or autism spectrum disorder. Complete information on this HTCC determination is available here: https://www.hca.wa.gov/about-hca/health-technology-assessment/health-technology-reviews.

Regulatory authority and related information

End of main content, page footer follows.

Access Washington official state portal

   © Washington State Dept. of Labor & Industries. Use of this site is subject to the laws of the state of Washington.

Help us improve